Johnson & Johnson (JNJ)
NYSE · Healthcare · Drug Manufacturers - General
Johnson & Johnson is a Healthcare company with a market capitalization of $613.02B, a trailing P/E ratio of 29.5, and a dividend yield of 2.12%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 14, 2026 | $2.14 | $2.27 | -5.7% |
| Q4 2025 | January 21, 2026 | $2.46 | $2.46 | +0.0% |
| Q3 2025 | October 14, 2025 | $2.80 | $2.76 | +1.5% |
| Q2 2025 | July 16, 2025 | $2.77 | $2.68 | +3.4% |
| Q1 2025 | April 15, 2025 | $2.77 | $2.58 | +7.4% |
| Q4 2024 | January 22, 2025 | $2.04 | $2.01 | +1.5% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Johnson & Johnson's market cap?
As of June 29, 2026, Johnson & Johnson (JNJ) has a market capitalization of $613.02B.
What is Johnson & Johnson's P/E ratio?
Johnson & Johnson trades at a trailing price-to-earnings (P/E) ratio of 29.5. Its forward P/E is 22.0.
Does Johnson & Johnson pay a dividend?
Yes — Johnson & Johnson pays a dividend yielding 2.12%, an annual payout of $5.20 per share.
What sector is JNJ in?
Johnson & Johnson is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What was Johnson & Johnson's revenue?
In its latest reported fiscal year (ending December 31, 2025), Johnson & Johnson reported revenue of $94.19B and net income of $26.80B.
Ask your own questions about JNJ
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.